Mannosylated Polycations Target CD206(+) Antigen-Presenting Cells and Mediate T-Cell-Specific Activation in Cancer Vaccination

[Image: see text] Immunotherapy is deemed one of the most powerful therapeutic approaches to treat cancer. However, limited response and tumor specificity are still major challenges to address. Herein, mannosylated polycations targeting mannose receptor- are developed as vectors for plasmid DNA (pDN...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellato, Federica, Feola, Sara, Dalla Verde, Gloria, Bellio, Greta, Pirazzini, Marco, Salmaso, Stefano, Caliceti, Paolo, Cerullo, Vincenzo, Mastrotto, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748946/
https://www.ncbi.nlm.nih.gov/pubmed/36394394
http://dx.doi.org/10.1021/acs.biomac.2c00993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748946/
https://www.ncbi.nlm.nih.gov/pubmed/36394394
http://dx.doi.org/10.1021/acs.biomac.2c00993

Ejemplares similares